SHAREHOLDER ALERT: US Pension Funds' Securities Fraud

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: US Pension Funds' Securities Fraud Claims for Purchases Abroad Allowed to Proceed Against BP

NEW YORK, Oct. 10, 2013 (GLOBE NEWSWIRE) -- In a landmark case spearheaded by Pomerantz Grossman Hufford Dahlstrom & Gross LLP (the "Pomerantz Firm"), the U.S. District Court for the Southern District of Texas issued a decision made public today holding that three of the Pomerantz Firm's clients, Alameda County Employees' Retirement Association, Employees' Retirement System of the City of Providence, and State-Boston Retirement System, can pursue common law fraud and negligence claims against British Petroleum ("BP") in connection with their purchases of BP common stock on the London Stock Exchange ("LSE") from January 2007 through June 2010. These claims concern alleged false and misleading statements made by BP concerning its commitment to safety reforms and stock prices declines in the wake of the 2010 Deepwater Horizon oil spill.  

The case is at the cutting edge of securities litigation. The U.S. Supreme Court's decision in Morrison v. National Australia Bank has been interpreted to bar investors from recovering losses under the U.S. federal securities laws for purchases made on foreign exchanges such as the LSE. In today's decision, however, the Court largely denied defendants' motion to dismiss these plaintiffs' claims and allowed them to pursue common law claims under English law, which significantly overlaps with U.S. common law.  

There is no class action asserting common law claims to recover losses associated with BP common stock purchases. Thus, other investors who wish to pursue such claims must formally bring suit in order to obtain any potential recovery. If they do so, they may pursue any ADS losses in the same action. The Pomerantz Firm is pursuing similar claims on behalf of over twenty other institutional investors, including U.S. pension funds, U.S. limited partnerships and ERISA trusts, and public and private pension funds in Europe and Australia.

As noted by Marc Gross, the Pomerantz Firm's Managing Partner, "This decision is a watershed. It demonstrates that even though the U.S. federal securities laws may not reach foreign-traded securities, those who commit fraud in connection with such securities can still be held accountable in U.S. federal courts under the common law, especially where much of the misconduct was centered in the US. As we have done for 75 years, the Pomerantz Firm has once again made the law for the benefit of investors."

The BP litigation at the Pomerantz Firm has been spearheaded by Marc Gross, Jeremy Lieberman, Jason Cowart, Matthew Tuccillo, Emma Gilmore, and Jessica Dell.  

The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the Dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of investors. See www.pomerantzlaw.com .

Jason S. Cowart Pomerantz Grossman Hufford Dahlstrom & Gross LLP 212-661-1100

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 20

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 11

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 16

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 15

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 20

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 22

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Celebree Gains Franchise Momentum: A New Frontier

Updated Category News Views 13

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 2

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 7

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading

Top 5 Most Recently Viewed Articles

Urgent Alert for Investors Ahead of Securities Class Action

Updated Category News Views 137

Urgent Alert for Investors Ahead of Securities Class Action The law firm Kessler Topaz Meltzer & Check, LLP is reaching out to investors regarding a significant securities fraud class action lawsuit against Cassava Sciences, Inc. (NASDAQ: SAVA). This lawsuit highlights serious allegations against the company that all investors should be aware of as they could potentially...

Continue Reading
Celebrating Excellence in Glass Packaging: Awards and Innovations

Updated Category News Views 203

Ardagh Glass Packaging Customers Shine at Awards Ceremony In an exciting recent announcement, Ardagh Glass Packaging-North America has celebrated the achievements of five of its customers, who were honored with prestigious awards for their innovative glass packaging. This recognition from the Glass Packaging Institute showcases both creativity and sustainability in the...

Continue Reading
SLR Consulting Expands Global Reach with Malk Partners Acquisition

Updated Category News Views 237

SLR Consulting Expands Global Reach with Malk Partners Acquisition SLR Consulting (NASDAQ: SLR), a prominent player in the sustainability sector, has announced an exciting agreement to acquire Malk Partners. This acquisition marks a significant milestone for SLR as it aims to enhance its offerings and reach within the environmental, social, and governance (ESG) landscape....

Continue Reading
Unlocking the Hidden Value of Time: The LIFE Matrix Approach

Updated Category News Views 422

Measuring the True Value of Time In today's fast-paced world, filled with to-do lists and constant distractions, it is essential to recognize the significance of how we allocate our time. The recent findings from research conducted by esteemed academics redefine our understanding of time management. This innovative approach emphasizes the subjective value of our time...

Continue Reading
Hyundai Motor's Vision: A New Era of Hydrogen Energy Innovation

Updated Category News Views 267

Hyundai Motor Unveils New Hydrogen Fuel Cell Production Facility Hyundai Motor has taken a significant step forward by holding a groundbreaking ceremony for its new hydrogen fuel cell production facility in Ulsan, Korea. This ambitious project demonstrates Hyundai’s commitment to becoming a leader in the hydrogen industry. Major Investment and Production Goals With a...

Continue Reading